Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 101.80%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 101.80%
Sep 30, 2025 126.04%
Jun 30, 2025 191.95%
Mar 31, 2025 101.32%
Dec 31, 2024 26.45%
Sep 30, 2024 -154.43%
Jun 30, 2024 -76.30%
Mar 31, 2024 -111.74%
Dec 31, 2023 -94.79%
Sep 30, 2023 492.31%
Jun 30, 2023 -28.07%
Mar 31, 2023 6.10%
Dec 31, 2022 7.07%
Sep 30, 2022 -30.43%
Jun 30, 2022 -133.29%
Mar 31, 2022 -7,531.03%
Dec 31, 2021 -236.69%
Sep 30, 2021 -32.65%
Jun 30, 2021 70.25%
Mar 31, 2021 98.84%
Dec 31, 2020 56.01%
Sep 30, 2020 27.62%
Jun 30, 2020 -27.08%
Mar 31, 2020 10.93%
Dec 31, 2019 97.17%
Sep 30, 2019 40.41%
Jun 30, 2019 61.24%
Mar 31, 2019 46.72%
Dec 31, 2018 -99.54%
Sep 30, 2018 62.88%
Jun 30, 2018 48.32%
Mar 31, 2018 11.97%
Dec 31, 2017 -539.24%
Sep 30, 2017 -67.63%
Jun 30, 2017 -89.54%
Mar 31, 2017 -14.98%
Dec 31, 2016 35.40%
Sep 30, 2016 27.58%
Jun 30, 2016 -84.56%
Mar 31, 2016 -63.81%
Dec 31, 2015 -74.86%
Sep 30, 2015 -154.52%
Jun 30, 2015 0.25%
Mar 31, 2015 -28.39%
Dec 31, 2014 5.51%
Sep 30, 2014 37.19%
Jun 30, 2014 -11.72%
Mar 31, 2014 -47.83%
Dec 31, 2013 14.64%
Sep 30, 2013 -73.72%
Jun 30, 2013 -439.91%
Mar 31, 2013 -59.46%
Dec 31, 2012 -12.05%
Sep 30, 2012 20.38%
Jun 30, 2012 280.24%
Mar 31, 2012 -121.29%
Dec 31, 2011 35.33%
Sep 30, 2011 65.01%
Jun 30, 2011 80.24%